WIM
LTRN icon

Westside Investment Management’s Lantern Pharma LTRN Stock Holding History

Westside Investment Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
47,850
-2,200
-4% -$6.45K 0.03% 312
2026
Q1 		$68.6K Buy
50,050
+14,150
+39% +$39.6K 0.01% 494
2025
Q4 		$109K Hold
35,900
– – 0.02% 378
2025
Q3 		$156K Hold
35,900
– – 0.02% 319
2025
Q2 		$113K Buy
35,900
+5,250
+17% +$17.7K 0.02% 328
2025
Q1 		$109K Hold
30,650
– – 0.02% 304
2024
Q4 		$97.8K Hold
30,650
– – 0.02% 315
2024
Q3 		$112K Buy
30,650
+19,150
+167% +$78.9K 0.02% 304
2024
Q2 		$53.7K Buy
+11,500
New +$69.2K 0.01% 377

Other funds holding LTRN

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
EF
Entrust Financial Wayne, Pennsylvania $154M AUM
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
KFI
Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return

Westside Investment Management's LTRN Position: Q2 2026 in Review

Westside Investment Management reduced its Lantern Pharma (LTRN) stake by 4.4% in Q2 2026, selling an estimated $6.45K and leaving 47,850 shares worth $200K. The position accounts for 0.03% of the portfolio, ranked #312.

Westside Investment Management first reported a position in LTRN in Q2 2024 and has held it in 9 quarters since. 8 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Westside Investment Management held 47,850 shares of Lantern Pharma worth $200K as of Q2 2026.
  • Westside Investment Management sold 2,200 Lantern Pharma shares in Q2 2026, an estimated $6.45K.
  • Lantern Pharma made up 0.03% of Westside Investment Management's portfolio in Q2 2026, its #312 holding.
  • Westside Investment Management first reported a position in Lantern Pharma in Q2 2024 and has held it in 9 quarters since.
  • 8 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.